These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

67 related items for PubMed ID: 20394767

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. The effects of sex and neonatal maternal separation on fear-potentiated and light-enhanced startle.
    de Jongh R, Geyer MA, Olivier B, Groenink L.
    Behav Brain Res; 2005 Jun 20; 161(2):190-6. PubMed ID: 15878207
    [Abstract] [Full Text] [Related]

  • 4. Activation of the septohippocampal system differentiates anxiety from fear in startle paradigms.
    Veening JG, Böcker KB, Verdouw PM, Olivier B, De Jongh R, Groenink L.
    Neuroscience; 2009 Nov 10; 163(4):1046-60. PubMed ID: 19580851
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Benzodiazepines have no effect on fear-potentiated startle in humans.
    Baas JM, Grillon C, Böcker KB, Brack AA, Morgan CA, Kenemans JL, Verbaten MN.
    Psychopharmacology (Berl); 2002 May 10; 161(3):233-47. PubMed ID: 12021826
    [Abstract] [Full Text] [Related]

  • 7. The light-enhanced startle paradigm as a putative animal model for anxiety: effects of chlordiazepoxide, flesinoxan and fluvoxamine.
    de Jongh R, Groenink L, van Der Gugten J, Olivier B.
    Psychopharmacology (Berl); 2002 Jan 10; 159(2):176-80. PubMed ID: 11862346
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Quantifying fear potentiated startle using absolute versus proportional increase scoring methods: implications for the neurocircuitry of fear and anxiety.
    Walker DL, Davis M.
    Psychopharmacology (Berl); 2002 Nov 10; 164(3):318-28. PubMed ID: 12424556
    [Abstract] [Full Text] [Related]

  • 10. Light-enhanced startle: further pharmacological and behavioral characterization.
    Walker DL, Davis M.
    Psychopharmacology (Berl); 2002 Jan 10; 159(3):304-10. PubMed ID: 11862363
    [Abstract] [Full Text] [Related]

  • 11. Effects of clonidine injections into the bed nucleus of the stria terminalis on fear and anxiety behavior in rats.
    Schweimer J, Fendt M, Schnitzler HU.
    Eur J Pharmacol; 2005 Jan 10; 507(1-3):117-24. PubMed ID: 15659301
    [Abstract] [Full Text] [Related]

  • 12. Differential effects of alprazolam on the baseline and fear-potentiated startle reflex in humans: a dose-response study.
    Riba J, Rodríguez-Fornells A, Urbano G, Morte A, Antonijoan R, Barbanoj MJ.
    Psychopharmacology (Berl); 2001 Oct 10; 157(4):358-67. PubMed ID: 11605094
    [Abstract] [Full Text] [Related]

  • 13. Pharmacological dissociation of moderate and high contextual fear as assessed by freezing behavior and fear-potentiated startle.
    Santos JM, Gárgaro AC, Oliveira AR, Masson S, Brandão ML.
    Eur Neuropsychopharmacol; 2005 Mar 10; 15(2):239-46. PubMed ID: 15695072
    [Abstract] [Full Text] [Related]

  • 14. Protein synthesis and the mechanisms of lasting change in anxiety induced by severe stress.
    Adamec R, Strasser K, Blundell J, Burton P, McKay DW.
    Behav Brain Res; 2006 Feb 28; 167(2):270-86. PubMed ID: 16256211
    [Abstract] [Full Text] [Related]

  • 15. Differential regulation of the expression of contextual freezing and fear-potentiated startle by 5-HT mechanisms of the median raphe nucleus.
    Silva RC, Gárgaro AC, Brandão ML.
    Behav Brain Res; 2004 May 05; 151(1-2):93-101. PubMed ID: 15084425
    [Abstract] [Full Text] [Related]

  • 16. Modulation of fear-potentiated startle and vocalizations in juvenile rhesus monkeys by morphine, diazepam, and buspirone.
    Winslow JT, Noble PL, Davis M.
    Biol Psychiatry; 2007 Feb 01; 61(3):389-95. PubMed ID: 16730332
    [Abstract] [Full Text] [Related]

  • 17. Anxiolytic-like effects of kappa-opioid receptor antagonists in models of unlearned and learned fear in rats.
    Knoll AT, Meloni EG, Thomas JB, Carroll FI, Carlezon WA.
    J Pharmacol Exp Ther; 2007 Dec 01; 323(3):838-45. PubMed ID: 17823306
    [Abstract] [Full Text] [Related]

  • 18. Latent inhibition of fear potentiated startle in rats.
    Schauz C, Koch M.
    Behav Pharmacol; 1998 Mar 01; 9(2):175-8. PubMed ID: 10065937
    [Abstract] [Full Text] [Related]

  • 19. Role of gastrin-releasing peptide and neuromedin B in anxiety and fear-related behavior.
    Bédard T, Mountney C, Kent P, Anisman H, Merali Z.
    Behav Brain Res; 2007 Apr 16; 179(1):133-40. PubMed ID: 17335915
    [Abstract] [Full Text] [Related]

  • 20. Temporary inactivation of the nucleus accumbens disrupts acquisition and expression of fear-potentiated startle in rats.
    Schwienbacher I, Fendt M, Richardson R, Schnitzler HU.
    Brain Res; 2004 Nov 19; 1027(1-2):87-93. PubMed ID: 15494160
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 4.